Multidrug-Resistant HIV-1

May 2004
Clinical Infectious Diseases;5/15/2004, Vol. 38 Issue 10, p1507
Academic Journal
No abstract available.


Related Articles

  • This Technique For Combating Drug-Resistant HIV Is Not Effective.  // RN;Nov2003, Vol. 66 Issue 11, p18 

    Reports on an evaluation of the effectiveness of treatment interruptions in patients with multidrug-resistant HIV infections. Purpose of treatment interruptions; Disease progression in patients who participated in the study.

  • First Case of Primary Multidrug-Resistant Pulmonary Tuberculosis in a HIV-Infected Patient in Hungary. Sárvári, C.; Szlávik, J.; Bánhegyi, D. // European Journal of Clinical Microbiology & Infectious Diseases;Oct2003, Vol. 22 Issue 10, p635 

    This article reports on the first case of primary multidrug-resistant pulmonary tuberculosis in a HIV-infected patient in Hungary. The risk factors for multidrug-resistant tuberculosis include: previous antituberculosis treatment or relapse; infection originating from a "hot spot" region; a...

  • Multidrug-resistant TB in HIV-negative patients.  // American Family Physician;2/15/1996, Vol. 53 Issue 3, p964 

    Presents the study `Multidrug-Resistant Tuberculosis in Patients Without HIV Infection,' by E.E. Telzak, et al., published in the 1995 issue of `New England Journal of Medicine.' Treatment response to isoniazid of patients with drug-resistant tuberculosis; Second-line medications for...

  • Switch from raltegravir to enfuvirtide may be safe and effective for patients with multidrug resistant HIV.  // Infectious Disease News;Nov2009, Vol. 22 Issue 11, p25 

    This article discusses a study which suggests that target human immunodeficiency virus (HIV) ribonucleic acid levels may be reached in patients with multidrug-resistant HIV who continued with enfuvirtide or who switched to raltegravir.

  • Multidrug resistant tuberculosis and HIV: A personal experience. Mayho, Paul // BMJ: British Medical Journal (International Edition);11/15/97, Vol. 315 Issue 7118, p1317 

    Talks about the author's experience with multidrug resistant tuberculosis. Diagnosis of the author's condition three months after he was confined in a hospital; Tests conducted on the author; Treatment with a cocktail of drugs; HIV status of the author.

  • GLOBE IN BRIEF. Currie, Donya // Nation's Health;May/Jun2012, Vol. 42 Issue 4, p27 

    This section offers health news briefs including the high levels of multidrug-resistant tuberculosis recorded by the World Health Organization (WHO), the provision of humanitarian assistance to the elderly and people with disabilities, and the use of antiretroviral therapy to prevent HIV.

  • Antiretrovirals/atovaquone/proguanil interaction.  // Reactions Weekly;8/6/2011, Issue 1363, p9 

    The article describes the case of a 32-year-old woman with multi-drug resistant HIV-1 who experienced increases in her serum concentrations of etravirine and saquinavir during concomitant use with atovaquone/proguanil.

  • Concomitant Multidrug-Resistant Pulmonary Tuberculosis and Susceptible Tuberculous Meningitis. Bernard, Christine; Brossier, Florence; Fréchet-Jachym, Mathilde; Morand, Philippe C.; Coignard, Sophie; Aslangul, Elisabeth; Aubry, Alexandra; Jarlier, Vincent; Sougakoff, Wladimir; Veziris, Nicolas // Emerging Infectious Diseases;Mar2014, Vol. 20 Issue 3, p506 

    A letter to the editor about a 34-year-old HIV-seronegative male patient who experienced multidrug-resistant pulmonary tuberculosis and susceptible tuberculous meningitis is presented.

  • MDR-TB. Shearer, Brian G. // Journal of the American Dental Association (JADA);Jan1994, Vol. 125 Issue 1, p42 

    Discusses epidemiological trends and demographics of multidrug-resistant tuberculosis (MDR-TB). Impact of the HIV epidemic on the epidemiology of TB; Risk of TB transmission in the dental office; Implications for dentistry; Safety measures.

  • Reply to Gonzalez-Serna et al. Sood, Neeraj; Wagner, Zachary; Jaycocks, Amber; Drabo, Emmanuel; Vardavas, Raffaele // Clinical Infectious Diseases;Aug2013, Vol. 57 Issue 3, p479 

    A response to letter to the editor on the article "Test-and-treat: Strategy for Control of HIV and AIDS Leads to a Decrease, not an Increase, of Multidrug Resistant Viruses" by Sema Gonzalez and coworkers in the 2013 issue is presented.


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics